Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 371 entries
Sorted by: Best Match Show Resources per page
Complexities of classifying patients with Hodgkin disease: a plea for a prognostic index.

American journal of hematology

Schilling RF.
PMID: 655161
Am J Hematol. 1978;4(1):93-5. doi: 10.1002/ajh.2830040112.

No abstract available.

Cite
Schilling RF. Complexities of classifying patients with Hodgkin disease: a plea for a prognostic index. Am J Hematol. 1978;4(1):93-5doi: 10.1002/ajh.2830040112.
Schilling, R. F. (1978). Complexities of classifying patients with Hodgkin disease: a plea for a prognostic index. American journal of hematology, 4(1), 93-5. https://doi.org/10.1002/ajh.2830040112
Schilling, R F. "Complexities of classifying patients with Hodgkin disease: a plea for a prognostic index." American journal of hematology vol. 4,1 (1978): 93-5. doi: https://doi.org/10.1002/ajh.2830040112
Schilling RF. Complexities of classifying patients with Hodgkin disease: a plea for a prognostic index. Am J Hematol. 1978;4(1):93-5. doi: 10.1002/ajh.2830040112. PMID: 655161.
Copy Download .nbib Format: NLM
Circulating aberrant plasma cells allows risk stratification of patients with myeloma.

American journal of hematology

Periago A, Campillo JA, Mrowiec A, Gimeno L, Montes NR, Martínez-Sánchez MV, Cabañas-Perianes V, García-Garay C, Bolarin JM, Blasco-Mogorrón A, Muro M, Berenguer M, Moraleda JM, García-Alonso AM, Minguela A.
PMID: 27220360
Am J Hematol. 2016 Sep;91(9):E353-E355. doi: 10.1002/ajh.24431. Epub 2016 May 24.

No abstract available.

Cite
Periago A, Campillo JA, Mrowiec A, et al. Circulating aberrant plasma cells allows risk stratification of patients with myeloma. Am J Hematol. 2016;91(9):E353-E355doi: 10.1002/ajh.24431.
Periago, A., Campillo, J. A., Mrowiec, A., Gimeno, L., Montes, N. R., Martínez-Sánchez, M. V., Cabañas-Perianes, V., García-Garay, C., Bolarin, J. M., Blasco-Mogorrón, A., Muro, M., Berenguer, M., Moraleda, J. M., García-Alonso, A. M., & Minguela, A. (2016). Circulating aberrant plasma cells allows risk stratification of patients with myeloma. American journal of hematology, 91(9), E353-E355. https://doi.org/10.1002/ajh.24431
Periago, Adela, et al. "Circulating aberrant plasma cells allows risk stratification of patients with myeloma." American journal of hematology vol. 91,9 (2016): E353-E355. doi: https://doi.org/10.1002/ajh.24431
Periago A, Campillo JA, Mrowiec A, Gimeno L, Montes NR, Martínez-Sánchez MV, Cabañas-Perianes V, García-Garay C, Bolarin JM, Blasco-Mogorrón A, Muro M, Berenguer M, Moraleda JM, García-Alonso AM, Minguela A. Circulating aberrant plasma cells allows risk stratification of patients with myeloma. Am J Hematol. 2016 Sep;91(9):E353-E355. doi: 10.1002/ajh.24431. Epub 2016 May 24. PMID: 27220360.
Copy Download .nbib Format: NLM
Effect of Vitamin D Supplementation on Breast Cancer Biomarkers: CALGB 70806 (Alliance) Study Design and Baseline Data.

American journal of hematology/oncology

Apoe O, Jung SH, Liu H, Seisler DK, Charlamb J, Zekan P, Wang LX, Unzeitig GW, Garber J, Marshall J, Wood M.
PMID: 29081880
Am J Hematol Oncol. 2016 Jul;12(7):4-9.

One in eight women will develop breast cancer over their lifetime with 230,000 women diagnosed in 2015. For this reason, breast cancer prevention efforts are essential. Vitamin D, with anticancer properties, may have a role in prevention of some...

Cite
Apoe O, Jung SH, Liu H, et al. Effect of Vitamin D Supplementation on Breast Cancer Biomarkers: CALGB 70806 (Alliance) Study Design and Baseline Data. Am J Hematol Oncol. 2016;12(7):4-9
Apoe, O., Jung, S. H., Liu, H., Seisler, D. K., Charlamb, J., Zekan, P., Wang, L. X., Unzeitig, G. W., Garber, J., Marshall, J., & Wood, M. (2016). Effect of Vitamin D Supplementation on Breast Cancer Biomarkers: CALGB 70806 (Alliance) Study Design and Baseline Data. American journal of hematology/oncology, 12(7), 4-9.
Apoe, Ogheneruona, et al. "Effect of Vitamin D Supplementation on Breast Cancer Biomarkers: CALGB 70806 (Alliance) Study Design and Baseline Data." American journal of hematology/oncology vol. 12,7 (2016): 4-9.
Apoe O, Jung SH, Liu H, Seisler DK, Charlamb J, Zekan P, Wang LX, Unzeitig GW, Garber J, Marshall J, Wood M. Effect of Vitamin D Supplementation on Breast Cancer Biomarkers: CALGB 70806 (Alliance) Study Design and Baseline Data. Am J Hematol Oncol. 2016 Jul;12(7):4-9. PMID: 29081880; PMCID: PMC5656380.
Copy Download .nbib Format: NLM
Improving prognostic tools in systemic mastocytosis: Insights from mutations.

American journal of hematology

Pieri L, Vannucchi AM.
PMID: 27397606
Am J Hematol. 2016 Sep;91(9):867-8. doi: 10.1002/ajh.24472. Epub 2016 Aug 04.

No abstract available.

Cite
Pieri L, Vannucchi AM. Improving prognostic tools in systemic mastocytosis: Insights from mutations. Am J Hematol. 2016;91(9):867-8doi: 10.1002/ajh.24472.
Pieri, L., & Vannucchi, A. M. (2016). Improving prognostic tools in systemic mastocytosis: Insights from mutations. American journal of hematology, 91(9), 867-8. https://doi.org/10.1002/ajh.24472
Pieri, Lisa, and Vannucchi, Alessandro M. "Improving prognostic tools in systemic mastocytosis: Insights from mutations." American journal of hematology vol. 91,9 (2016): 867-8. doi: https://doi.org/10.1002/ajh.24472
Pieri L, Vannucchi AM. Improving prognostic tools in systemic mastocytosis: Insights from mutations. Am J Hematol. 2016 Sep;91(9):867-8. doi: 10.1002/ajh.24472. Epub 2016 Aug 04. PMID: 27397606.
Copy Download .nbib Format: NLM
Notice of retraction. Alteration of p73 in acute myelogenous leukemia.

American journal of hematology

Sahu GR, Mishra R, Nagpal JK, Das BR.
PMID: 18615454
Am J Hematol. 2008 Aug;83(8):691. doi: 10.1002/ajh.21232.

No abstract available.

Cite
Sahu GR, Mishra R, Nagpal JK, et al. Notice of retraction. Alteration of p73 in acute myelogenous leukemia. Am J Hematol. 2008;83(8):691doi: 10.1002/ajh.21232.
Sahu, G. R., Mishra, R., Nagpal, J. K., & Das, B. R. (2008). Notice of retraction. Alteration of p73 in acute myelogenous leukemia. American journal of hematology, 83(8), 691. https://doi.org/10.1002/ajh.21232
Sahu, Geeta Ram, et al. "Notice of retraction. Alteration of p73 in acute myelogenous leukemia." American journal of hematology vol. 83,8 (2008): 691. doi: https://doi.org/10.1002/ajh.21232
Sahu GR, Mishra R, Nagpal JK, Das BR. Notice of retraction. Alteration of p73 in acute myelogenous leukemia. Am J Hematol. 2008 Aug;83(8):691. doi: 10.1002/ajh.21232. PMID: 18615454.
Copy Download .nbib Format: NLM
Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia.

American journal of hematology

Chyla B, Daver N, Doyle K, McKeegan E, Huang X, Ruvolo V, Wang Z, Chen K, Souers A, Leverson J, Potluri J, Boghaert E, Bhathena A, Konopleva M, Popovic R.
PMID: 29770480
Am J Hematol. 2018 May 17; doi: 10.1002/ajh.25146. Epub 2018 May 17.

No abstract available.

Cite
Chyla B, Daver N, Doyle K, et al. Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia. Am J Hematol. 2018;doi: 10.1002/ajh.25146.
Chyla, B., Daver, N., Doyle, K., McKeegan, E., Huang, X., Ruvolo, V., Wang, Z., Chen, K., Souers, A., Leverson, J., Potluri, J., Boghaert, E., Bhathena, A., Konopleva, M., & Popovic, R. (2018). Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia. American journal of hematology, . https://doi.org/10.1002/ajh.25146
Chyla, Brenda, et al. "Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia." American journal of hematology vol. (2018). doi: https://doi.org/10.1002/ajh.25146
Chyla B, Daver N, Doyle K, McKeegan E, Huang X, Ruvolo V, Wang Z, Chen K, Souers A, Leverson J, Potluri J, Boghaert E, Bhathena A, Konopleva M, Popovic R. Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia. Am J Hematol. 2018 May 17; doi: 10.1002/ajh.25146. Epub 2018 May 17. PMID: 29770480; PMCID: PMC6120451.
Copy Download .nbib Format: NLM
Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma.

American journal of hematology

Ekberg S, Jerkeman M, Andersson PO, Enblad G, Wahlin BE, Hasselblom S, Andersson TM, Eloranta S, Smedby KE.
PMID: 29770496
Am J Hematol. 2018 May 17; doi: 10.1002/ajh.25147. Epub 2018 May 17.

Survival has improved among patients with diffuse large B-cell lymphoma (DLBCL) with the addition of anti-CD20 antibody therapy. We aimed to quantify trends and remaining loss in expectation of life (LEL) due to DLBCL at a national population-based level....

Cite
Ekberg S, Jerkeman M, Andersson PO, et al. Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma. Am J Hematol. 2018;doi: 10.1002/ajh.25147.
Ekberg, S., Jerkeman, M., Andersson, P. O., Enblad, G., Wahlin, B. E., Hasselblom, S., Andersson, T. M., Eloranta, S., & Smedby, K. E. (2018). Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma. American journal of hematology, . https://doi.org/10.1002/ajh.25147
Ekberg, Sara, et al. "Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma." American journal of hematology vol. (2018). doi: https://doi.org/10.1002/ajh.25147
Ekberg S, Jerkeman M, Andersson PO, Enblad G, Wahlin BE, Hasselblom S, Andersson TM, Eloranta S, Smedby KE. Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma. Am J Hematol. 2018 May 17; doi: 10.1002/ajh.25147. Epub 2018 May 17. PMID: 29770496.
Copy Download .nbib Format: NLM
Flow cytometric quantification of neutrophil extracellular traps: Limitations of the methodological approach.

American journal of hematology

[No authors listed]
PMID: 27527837
Am J Hematol. 2016 Sep;91(9):965. doi: 10.1002/ajh.24393. Epub 2016 May 11.

No abstract available.

Cite
Flow cytometric quantification of neutrophil extracellular traps: Limitations of the methodological approach. Am J Hematol. 2016;91(9):965doi: 10.1002/ajh.24393.
(2016). Flow cytometric quantification of neutrophil extracellular traps: Limitations of the methodological approach. American journal of hematology, 91(9), 965. https://doi.org/10.1002/ajh.24393
"Flow cytometric quantification of neutrophil extracellular traps: Limitations of the methodological approach." American journal of hematology vol. 91,9 (2016): 965. doi: https://doi.org/10.1002/ajh.24393
Flow cytometric quantification of neutrophil extracellular traps: Limitations of the methodological approach. Am J Hematol. 2016 Sep;91(9):965. doi: 10.1002/ajh.24393. Epub 2016 May 11. PMID: 27527837.
Copy Download .nbib Format: NLM
Myeloma today: Disease definitions and treatment advances.

American journal of hematology

Rajkumar V.
PMID: 27527838
Am J Hematol. 2016 Sep;91(9):965. doi: 10.1002/ajh.24392. Epub 2016 May 11.

No abstract available.

Cite
Rajkumar V. Myeloma today: Disease definitions and treatment advances. Am J Hematol. 2016;91(9):965doi: 10.1002/ajh.24392.
Rajkumar, V. (2016). Myeloma today: Disease definitions and treatment advances. American journal of hematology, 91(9), 965. https://doi.org/10.1002/ajh.24392
Rajkumar, Vincent. "Myeloma today: Disease definitions and treatment advances." American journal of hematology vol. 91,9 (2016): 965. doi: https://doi.org/10.1002/ajh.24392
Rajkumar V. Myeloma today: Disease definitions and treatment advances. Am J Hematol. 2016 Sep;91(9):965. doi: 10.1002/ajh.24392. Epub 2016 May 11. PMID: 27527838.
Copy Download .nbib Format: NLM
Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemia.

American journal of hematology

[No authors listed]
PMID: 27527839
Am J Hematol. 2016 Sep;91(9):965. doi: 10.1002/ajh.24394. Epub 2016 May 24.

No abstract available.

Cite
Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemia. Am J Hematol. 2016;91(9):965doi: 10.1002/ajh.24394.
(2016). Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemia. American journal of hematology, 91(9), 965. https://doi.org/10.1002/ajh.24394
"Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemia." American journal of hematology vol. 91,9 (2016): 965. doi: https://doi.org/10.1002/ajh.24394
Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemia. Am J Hematol. 2016 Sep;91(9):965. doi: 10.1002/ajh.24394. Epub 2016 May 24. PMID: 27527839.
Copy Download .nbib Format: NLM
Fixed Low-Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Anemia in Nigeria.

American journal of hematology

Tayo BO, Akingbola TS, Saraf SL, Shah BN, Ezekekwu CA, Sonubi O, Hsu LL, Cooper RS, Gordeuk VR.
PMID: 29756251
Am J Hematol. 2018 May 14; doi: 10.1002/ajh.25143. Epub 2018 May 14.

No abstract available.

Cite
Tayo BO, Akingbola TS, Saraf SL, et al. Fixed Low-Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Anemia in Nigeria. Am J Hematol. 2018;doi: 10.1002/ajh.25143.
Tayo, B. O., Akingbola, T. S., Saraf, S. L., Shah, B. N., Ezekekwu, C. A., Sonubi, O., Hsu, L. L., Cooper, R. S., & Gordeuk, V. R. (2018). Fixed Low-Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Anemia in Nigeria. American journal of hematology, . https://doi.org/10.1002/ajh.25143
Tayo, Bamidele O, et al. "Fixed Low-Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Anemia in Nigeria." American journal of hematology vol. (2018). doi: https://doi.org/10.1002/ajh.25143
Tayo BO, Akingbola TS, Saraf SL, Shah BN, Ezekekwu CA, Sonubi O, Hsu LL, Cooper RS, Gordeuk VR. Fixed Low-Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Anemia in Nigeria. Am J Hematol. 2018 May 14; doi: 10.1002/ajh.25143. Epub 2018 May 14. PMID: 29756251; PMCID: PMC6235722.
Copy Download .nbib Format: NLM
Treatment with cyclosporin in auto-immune cytopenias in children: The experience from the French cohort OBS'CEREVANCE.

American journal of hematology

Penel Page M, Bertrand Y, Fernandes H, Kherfellah D, Leverger G, Leblanc T, Libbrecht C, Michel G, Jeziorski E, Armari-Alla C, Nelken B, Pellier I, Pasquet M, Perel Y, Aladjidi N.
PMID: 29756344
Am J Hematol. 2018 May 14; doi: 10.1002/ajh.25137. Epub 2018 May 14.

No abstract available.

Cite
Penel Page M, Bertrand Y, Fernandes H, et al. Treatment with cyclosporin in auto-immune cytopenias in children: The experience from the French cohort OBS'CEREVANCE. Am J Hematol. 2018;doi: 10.1002/ajh.25137.
Penel Page, M., Bertrand, Y., Fernandes, H., Kherfellah, D., Leverger, G., Leblanc, T., Libbrecht, C., Michel, G., Jeziorski, E., Armari-Alla, C., Nelken, B., Pellier, I., Pasquet, M., Perel, Y., & Aladjidi, N. (2018). Treatment with cyclosporin in auto-immune cytopenias in children: The experience from the French cohort OBS'CEREVANCE. American journal of hematology, . https://doi.org/10.1002/ajh.25137
Penel Page, Mathilde, et al. "Treatment with cyclosporin in auto-immune cytopenias in children: The experience from the French cohort OBS'CEREVANCE." American journal of hematology vol. (2018). doi: https://doi.org/10.1002/ajh.25137
Penel Page M, Bertrand Y, Fernandes H, Kherfellah D, Leverger G, Leblanc T, Libbrecht C, Michel G, Jeziorski E, Armari-Alla C, Nelken B, Pellier I, Pasquet M, Perel Y, Aladjidi N. Treatment with cyclosporin in auto-immune cytopenias in children: The experience from the French cohort OBS'CEREVANCE. Am J Hematol. 2018 May 14; doi: 10.1002/ajh.25137. Epub 2018 May 14. PMID: 29756344.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 371 entries